Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hims & Hers vs Peptivo

Hims & Hers
Graded #36

Higher grade

vs+20.9
Peptivo
Graded #330

Lower grade

The verdict

Hims & Hers takes it — 81/100 to 60.1/100.

Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHims & Hers +37
82
45
Dose & formulationHims & Hers +25
78
53
Clinical oversightHims & Hers +6
82
76
Labs & monitoringHims & Hers +15
80
65
FulfillmentHims & Hers +10
84
74
Contract termsHims & Hers +25
80
55
Hims & Hers · left barPeptivo · right bar

The numbers

MetricHims & HersPeptivo
WeighScore81/10060.1/100
GradeB−C
Scorecard rank#36#330
Semaglutide$199/moNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Hims & Hers

Graded #36 · B−

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

Where it loses points

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny
Peptivo

Graded #330 · C

Strengths

  • Low entry pricing — GLP-1 weight-loss plans starting at $169/mo, with free discreet shipping
  • Same-day provider visits and 24/7 provider messaging; 100% online
  • Compounded in the USA at FDA-registered labs; can also prescribe brand GLP-1 (Ozempic, Wegovy, Zepbound)
  • FSA/HSA eligible with upfront pricing

Where it loses points

  • GLP-1 products use generic names ('GLP-1 Daily Support', 'Weight Loss Boost') — semaglutide/tirzepatide not clearly broken out
  • Compounding pharmacy/lab partner not named
  • Limited published policies (privacy and terms only; no HIPAA notice or refund policy found)
  • Not LegitScript-certified (no certification displayed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard